Literature DB >> 10371673

Simian immunodeficiency virus as a model of human HIV disease.

A M Geretti1.   

Abstract

Because of strong clinical, pathological, virological and immunological analogies with HIV infection of humans, infection of macaques with SIV provides a valuable model for exploring crucial issues related to both the pathogenesis and prevention of HIV infection. The model has offered a unique setting for the preclinical evaluation of drugs, vaccines and gene-therapies against HIV, and has helped to identify many virus and host determinants of lentiviral disease. For instance, the importance of an intact nef gene for efficient lentivirus replication and disease induction, and the protective ability of live attenuated, nef-deleted viruses have been first demonstrated in macaques using molecular clones of SIV. More recently, the development of chimeric HIV-SIV vectors able to establish infection and induce disease in macaques has provided new opportunities for the evaluation of vaccination strategies based upon HIV antigens. The aim of this review is to describe the natural course of SIV infection in macaques and to outline how this model has contributed to our understanding of the complex interaction between lentiviruses and host immune system.

Entities:  

Mesh:

Year:  1999        PMID: 10371673     DOI: 10.1002/(sici)1099-1654(199901/03)9:1<57::aid-rmv237>3.0.co;2-1

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  7 in total

1.  Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects.

Authors:  Yvonne M Mueller; Constantinos Petrovas; Duc H Do; Susan R Altork; Tracy Fischer-Smith; Jay Rappaport; John D Altman; Mark G Lewis; Peter D Katsikis
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.

Authors:  Li-Mei Chen; Gabriel Briones; Ruben O Donis; Jorge E Galán
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.

Authors:  S M Blower; K Koelle; D E Kirschner; J Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells.

Authors:  D S An; R P Wersto; B A Agricola; M E Metzger; S Lu; R G Amado; I S Chen; R E Donahue
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.

Authors:  Y Guan; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 6.  Dissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization.

Authors:  Jonathan D Steckbeck; Kelly Stefano Cole
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.

Authors:  Arlin B Rogers; Candace K Mathiason; Edward A Hoover
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.